Catalysts

Catalysts — What Can Move the Stock

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The next six months hinge on two PTSB milestones and one earnings print. The deal-announcement re-rate has already happened; the next leg requires (i) the 21 July H1 2026 result to validate that risk costs are not breaking the FY24 ECL-overlay tail open, (ii) the scheme of arrangement work (shareholder vote, ECB/CCPC clearance, Irish High Court sanction) to land cleanly between now and Q4 2026, and (iii) the CET1 path to ~17% by end-Q2 2026 to print as guided so the deal stays self-funded. Six hard-dated events sit in the window. The calendar is busy and decision-relevant — this is not a drift tape.

Catalyst Setup

Ranked Catalyst Timeline

The ranking is decision-value, not chronology. The 21 July H1 result outranks the 3 June Goldman conference because the conference does not change underwriting; H1 can. The PTSB closing milestones outrank Q3 2026 results because closing is the binary that resolves the bull/bear deadlock the market has held since 14 April. Items 8–10 are continuous watchpoints rather than scheduled events; they belong on the radar but are not what the calendar is about.

Impact Matrix

Three catalysts actually resolve the bull/bear debate: H1 results, PTSB closing milestones, and the CET1 path. The other three add information without resolving the central question of whether 25%+ RoTCE is structural through a +40% balance-sheet expansion. The matrix is built for an investor who does not want to be paid to learn additional facts — only to learn the ones that change underwriting.

Next 90 Days

The 90-day calendar is front-loaded into late-June and late-July: a sector conference, the scheme circular window, and the H1 print. Every other piece of the catalyst map waits behind the H1 disclosure. A PM with a position should plan around 21 July as the single date the position has to defend against; a PM looking to enter has the conferences and the scheme-circular window to assess whether the bull thesis is still inside its delivery envelope.

What Would Change the View

The investment debate updates on three observable signals over the next six months. First, the standalone risk-cost print at H1 — anything inside 35–40 bps on the underlying book invalidates the bear's primary trigger that the FY24 16-bp reading was reservoir-funded; anything north of 45 bps converts the bear's "earnings flatter unwinding" thesis from claim to evidence. Second, the shape of the PTSB scheme path — a clean EGM in Q3 with no minority dissent, ECB clearance inside the typical 4–6 month window, and a calendared High Court hearing kills the deal-break tail and lets the bull case run; any of those three slipping reopens the dilution and rating-action overhangs. Third, the CET1 walk disclosed at H1 — execution of the full 250-basis-point capital build (200 bp from the H1 dividend skip plus 50 bp from RWA / SRT actions) confirms the self-funding narrative the bull thesis rests on; "alternative actions" language pushes the dilution-overhang language from background to foreground. Lower-priority signals — Knab-specific disclosure at Q3, rating reviews, technical level breaks — re-rank inside the same matrix without changing it. The Bull view at $228 holds while these three signals are intact; the Bear $117 path requires at least two to break together; the Variant question (whether the 14-deal pattern recognition is sufficient for the 15th) gets answered, in either direction, on the H1 print and the closing-milestone string.